Andrew Wilson Global cash generation lead AstraZeneca “The Taulia solution is a business tool rather than a treasury tool. It’s a way of managing the relationship with suppliers. It gives our suppliers really good visibility into our processes, because they can see on our portal when we have approved their invoice for payment.” Andrew Wilson Global cash generation lead INDUSTRY Pharmaceutic al REVENUE $25 billion SPEND $5.6 billion # OF SUPPLIERS 9,000 Challenges Existing program with house bank JPMorgan with no scalability Clear, board-level, working capital target Why Taulia? We sold value, as opposed to features of a product Our experience and people were crucial – including creating a video with senior management at Taulia Our partnership with Greensill – a harmonized and flexible funding solution Results 1,200 suppliers enrolled $800 million (annualized) early payments offered $100 million in early payments taken $600 million in working capital freed up